Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 3;10(5):1031.
doi: 10.3390/jcm10051031.

Ocular Manifestations in Psoriasis Screening (OcMaPS) Questionnaire: A Useful Tool to Reveal Misdiagnosed Ocular Involvement in Psoriasis

Angelo Ruggiero  1 , Gabriella Fabbrocini  1 , Sara Cacciapuoti  1 , Eleonora Cinelli  1 , Lucia Gallo  1 , Matteo Megna  1
Affiliations

Ocular Manifestations in Psoriasis Screening (OcMaPS) Questionnaire: A Useful Tool to Reveal Misdiagnosed Ocular Involvement in Psoriasis

Angelo Ruggiero et al. J Clin Med. .

Abstract

Psoriasis is an immune-mediated, chronic inflammatory disease, which mainly affects the skin, although it has systemic pathological effects. Comorbidities of psoriasis include ocular disorders, which are often nonspecific or mildly symptomatic. The aim of this study was to show the importance of ocular-disease screening in psoriatic patients using the Ocular Manifestations in Psoriasis Screening (OcMaPS) questionnaire. Patients suffering from moderate-to-severe psoriasis referring at our outpatient-clinic were consecutively enrolled. Each patient was asked to complete a screening questionnaire (OcMaPS). Patients reporting ocular symptoms were referred for an ophthalmological examination. A total of 372 patients were enrolled in the study. Ocular symptoms were detected in 39 patients (10.5%), and 37 patients were referred to ophthalmological examination which confirmed the presence of ocular manifestation in 30 patients. There were three cases (10%) of uveitis, 14 (46.6%) of dry eye and 13 (43.3%) of cataract, in progress or already treated with surgery. In the remaining seven patients, no ocular manifestations were found. Ocular manifestations in psoriatic patients are not rare. It is important to be aware of ocular symptoms in psoriatic patients, screening patients (with a consultation or OcMaPS questionnaire), which leads to earlier diagnosis and treatment.

Keywords: ocular involvement in psoriasis; ocular psoriasis; psoriasis comorbidity; screening questionnaire.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Balato N., Napolitano M., Ayala F., Patruno C., Megna M., Tarantino G. Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation. World J. Gastroenterol. 2015;21:6892–6897. doi: 10.3748/wjg.v21.i22.6892. - DOI - PMC - PubMed
    1. Ruggiero A., Fabbrocini G., Cinelli E., Megna M. Efficacy and safety of guselkumab in psoriasis patients who failed usteki-numab and/or anti-interleukin-17 treatment: A real-life 52-week retrospective study. Dermatol. Ther. 2020;13:4673. - PubMed
    1. Oliveira M.d.F., Rocha B.d.O., Duarte G.V. Psoriasis: Classical and emerging comorbidities. An. Bras. Dermatol. 2015;90:9–20. doi: 10.1590/abd1806-4841.20153038. - DOI - PMC - PubMed
    1. Demerdjieva Z., Mazhdrakova I., Tsankov N. Ocular changes in patients with psoriasis. Clin. Dermatol. 2019;37:663–667. doi: 10.1016/j.clindermatol.2019.07.029. - DOI - PubMed
    1. Chimenti M.S., Triggianese P., Salandri G., Conigliaro P., Canofari C., Caso F., Costa L., Nucci C., Aiello F., Cesareo M., et al. A Multimodal Eye Assessment in Psoriatic Arthritis Patients sine-Psoriasis: Evidence for a Potential Association with Systemic Inflammation. J. Clin. Med. 2020;9:719. doi: 10.3390/jcm9030719. - DOI - PMC - PubMed

LinkOut - more resources